Filip Fogdestam
Corporate Officer/Principal bei AROCELL AB
Profil
Filip Fogdestam is currently working as a Logistics Director at AroCell AB.
Previously, he worked as a Marketing Director & General Manager at Maiia Diagnostics AB from 2012 to 2013.
He also served as a General Manager at Phadia AB and MIAB Mälainvest AB.
Mr. Fogdestam completed his undergraduate degree at the University of Uppsala and the Swedish University of Agricultural Sciences.
Aktive Positionen von Filip Fogdestam
Unternehmen | Position | Beginn |
---|---|---|
AROCELL AB | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Filip Fogdestam
Unternehmen | Position | Ende |
---|---|---|
Maiia Diagnostics AB | Sales & Marketing | 01.09.2013 |
MIAB Mälainvest AB
MIAB Mälainvest AB Medical SpecialtiesHealth Technology MIAB Mälainvest AB, a private company based in Uppsala, Sweden, was acquired by Phadia AB on March 02, 2006. Part of Thermo Fisher Scientific, Inc., MIAB Mälainvest AB supplies a wide range of rare and special allergens. | Corporate Officer/Principal | - |
Phadia AB
Phadia AB Medical SpecialtiesHealth Technology Phadia AB develops, manufactures and markets blood test systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases. The company was founded in 2004 and is headquartered in Uppdala, Sweden. | Corporate Officer/Principal | - |
Ausbildung von Filip Fogdestam
University of Uppsala | Undergraduate Degree |
Swedish University of Agricultural Sciences | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
AROCELL AB | Health Technology |
Private Unternehmen | 3 |
---|---|
Phadia AB
Phadia AB Medical SpecialtiesHealth Technology Phadia AB develops, manufactures and markets blood test systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases. The company was founded in 2004 and is headquartered in Uppdala, Sweden. | Health Technology |
MIAB Mälainvest AB
MIAB Mälainvest AB Medical SpecialtiesHealth Technology MIAB Mälainvest AB, a private company based in Uppsala, Sweden, was acquired by Phadia AB on March 02, 2006. Part of Thermo Fisher Scientific, Inc., MIAB Mälainvest AB supplies a wide range of rare and special allergens. | Health Technology |
Maiia Diagnostics AB |